Trades on 4 secondary markets

CytoVale

Cytovale is a San Francisco-based medical diagnostics company that develops early-detection technology for sepsis. Its flagship product, IntelliSep, is the first and only FDA-cleared in vitro diagnostic test for sepsis: it uses microfluidics, high-speed video, and computer-vision algorithms to measu

emerging 16.2 / 100 0 APIs View provider profile →

Company Healthcare Diagnostics Medical Devices Sepsis In Vitro Diagnostics

CytoVale is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.